1. Home
  2. TRVG vs ATYR Comparison

TRVG vs ATYR Comparison

Compare TRVG & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVG
  • ATYR
  • Stock Information
  • Founded
  • TRVG 2005
  • ATYR 2005
  • Country
  • TRVG Germany
  • ATYR United States
  • Employees
  • TRVG N/A
  • ATYR N/A
  • Industry
  • TRVG EDP Services
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TRVG Technology
  • ATYR Health Care
  • Exchange
  • TRVG Nasdaq
  • ATYR Nasdaq
  • Market Cap
  • TRVG 306.5M
  • ATYR 327.0M
  • IPO Year
  • TRVG N/A
  • ATYR 2015
  • Fundamental
  • Price
  • TRVG $4.73
  • ATYR $3.13
  • Analyst Decision
  • TRVG Hold
  • ATYR Strong Buy
  • Analyst Count
  • TRVG 5
  • ATYR 6
  • Target Price
  • TRVG $2.94
  • ATYR $18.60
  • AVG Volume (30 Days)
  • TRVG 119.6K
  • ATYR 1.7M
  • Earning Date
  • TRVG 04-29-2025
  • ATYR 03-13-2025
  • Dividend Yield
  • TRVG N/A
  • ATYR N/A
  • EPS Growth
  • TRVG N/A
  • ATYR N/A
  • EPS
  • TRVG N/A
  • ATYR N/A
  • Revenue
  • TRVG $477,118,749.00
  • ATYR $235,000.00
  • Revenue This Year
  • TRVG $9.85
  • ATYR $1,387.23
  • Revenue Next Year
  • TRVG $6.77
  • ATYR $873.22
  • P/E Ratio
  • TRVG N/A
  • ATYR N/A
  • Revenue Growth
  • TRVG N/A
  • ATYR N/A
  • 52 Week Low
  • TRVG $1.60
  • ATYR $1.42
  • 52 Week High
  • TRVG $5.45
  • ATYR $4.66
  • Technical
  • Relative Strength Index (RSI)
  • TRVG 55.76
  • ATYR 38.96
  • Support Level
  • TRVG $4.63
  • ATYR $3.20
  • Resistance Level
  • TRVG $5.45
  • ATYR $3.94
  • Average True Range (ATR)
  • TRVG 0.39
  • ATYR 0.32
  • MACD
  • TRVG 0.01
  • ATYR -0.06
  • Stochastic Oscillator
  • TRVG 53.46
  • ATYR 11.19

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. It derives a majority of revenue from the Developed Europe segment. The Developed Europe segment is comprised of Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, and others.

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: